Site notifications

Sub menu

 

 

Therapeutic Goods (Listing) Notice 1999 (No. 4)

Published

Published in the Commonwealth of Australia Special Gazette No. S 646, 23 December 1999

Therapeutic Goods Act 1989

I, GRANT TAMBLING, Parliamentary Secretary to the Minister for Health and Aged Care, acting on behalf of the Minister for Health and Aged Care and under subsection 17 (5) of the Therapeutic Goods Act 1989, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods:

  • therapeutic goods that contain as their active ingredients, colloidal anhydrous silica or silicon dioxide, where these goods are not presented in a dosage form that is in a powder form.

Dated 7 December 1999

Parliamentary Secretary to the Minister for Health and Aged Care

Topics

Related content

  • Therapeutic Goods (Listing) Notice 2000 (No. 1)

    Regulatory decision notices
    Listing notice - lactoferrin - bovine, colloidal anhydrous silica or silicon dioxide, glucosamine sulfate-potassium chloride complex or glucosamine sulfatesodium chloride complex, R,S- or R-alpha lipoic acid, levocarnitine, acctyllevocarnitine hydrochloride, propionyllcvocarnitine hydrochloride, levocarnitine hydrochloride, levocarnitine tartrate, levocarnitine fumarate or levocarnitine magnesium citrate, bromclain, lecithin, soy -soy phosphatidylserine-enriched

  • Therapeutic Goods (Listing) Notice 1999 (No. 2)

    Regulatory decision notices
    Listing notice - sodium selenite, selenomethionine, selenocysteine, high selenium yeast, Bifidobacterium longum strain BB536, beta-hydroxy-beta-methylbutyric acid, calcium beta-hvdroxy-beta-methylbutyrate, sodium beta-hydroxy-beta-methylbutyrate